1 / 67

Molecular Pathology of Kidney Diseases

Molecular Pathology of Kidney Diseases. Dr. K.W. Chan. 1. Hereditary Kidney Diseases. Adult polycystic disease Infantile polycystic disease Alport syndrome. 1. Hereditary Kidney Diseases. [Adult polycystic disease] Infantile polycystic disease Alport syndrome. Characteristics of APKD.

ariadne
Télécharger la présentation

Molecular Pathology of Kidney Diseases

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Molecular Pathology ofKidney Diseases Dr. K.W. Chan

  2. 1. Hereditary Kidney Diseases Adult polycystic disease Infantile polycystic disease Alport syndrome

  3. 1. Hereditary Kidney Diseases [Adult polycystic disease] Infantile polycystic disease Alport syndrome

  4. Characteristics of APKD • Gene frequency 1/1000. • Autosomal dominant. • Symptoms onset in middle age. • Large polycystic kidneys. • >50% end stage renal failure. • A disorder affecting multiple organ systems. • Genetically heterogeneous.

  5. Localization of APKD genes • 1986 (Reeders et al) • A gene locus of APKD (now called PKD1) was shown to be closely linked to the -globin locus on 16p. • 1988 (Kimberling) • Genetic heterogeniety of APKD was discovered. • 1992 (Peters et al) • The PKD2 locus was localized to 4q21-23.

  6. 1994 (EPKDC) • PKD1 identified to be a gene encoding a 14-kb transcript • encoding a 4,302 a.a. protein called polycystin-1 • 1996 (Mochizuki et al) • PKD2 was cloned and polycystin-2 characterized • 1997 (Ariza et al) • described a 2-generation Spanish family with PKD in which linkage to the PKD1 and PKD2 loci was excluded -> evidence of PKD3

  7. Localization of PKD1 • A Portuguese family with both APKD and TSC • Father normal karyotype • Mother 46,XX t(16;22)(p13.3;q11.21), suffers APKD • Son 45,XY 16pter-p13.3 and 22pter-q11.21, suffers TSC and APKD • The breakpoint at 16p13.3 has disrupted the PKD1

  8. Genetic Heterogeneity of APKD

  9. Characteristics of PKD1 • Located on 16p13.3 • ~52kb genomic DNA, 14kb mRNA, 46 exons, 4,302 a.a. • Encodes for polycystin 1, an integral membrane glycoprotein • 70% duplication on 16p13.1 - the HG area • HG-A 21 kb • HG-B 17 kb • HG-C 8.5 kb

  10. Characteristics of PKD2 • Located on 4q21-23. • Encodes a 4 kb mRNA, 968 a.a. product. • Encodes for polycystin 2, an integral membrane glycoprotein. • Polycystin 1 and 2 function together as part of a multi-component membrane-spanning complex involved in cell-cell or cell-matrix interactions.

  11. Polycystin 2 • Polycystin 2 has six transmembrane spans with intracellular amino- and carboxyl-termini. • It has amino acid similarity with PKD1, and the family of voltage-activated calcium (and sodium) channels • It contains a calcium-binding domain.

  12. Aims of genetic study • Early diagnosis, including prenatal and presymptomatic diagnosis. • Select embyro by “test tube baby” • Correlate between phenotype and genotype. • Understand mechanisms involved in cyst formation and other associated lesions of APKD at the molecular level.

  13. Problems in the study of PKD1 • Only about 2.5 kb out of the 14 kb transcript is not duplicated. • Mutations affecting the duplicated part are difficult to determine. • No “hot spot” mutations.

  14. Diagnosis by Imaging • Ultrasonography • Intravenous urography • Urogram with bolus intravenous nephrotomography • Computerized tomography

  15. Age No. of cysts Remarks < 30 2 Unilateral / Bilateral 30 – 59 2 In each kidney > 60 > 3 In each kidney Diagnostic Criteria of APKD

  16. Strategies for genetic study • Genetic linkage study for early diagnosis • Microsatellite studies in APKD kindreds • Mutation analysis • Sequencing • Only about 2.5 kb out of the 14 kb transcript is not duplicated. • Mutations affecting the duplicated part are difficult to determine. • No “hot spot” mutations.

  17. Mutation Identified

  18. Microsatellite Polymorphism • Variation in the number of dinucleotides within (AC)n or other simple sequence repeats

  19. Microsatellite Markers for PKD1

  20. Microsatellite Markers for PKD2

  21. Scope of work • Characterization of markers in HK Population (a sample of 63 unrelated adults) • 6 PKD1 markers, 3 PKD2 markers • Microsatellite haplotyping in 5 APKD families with a total of 42 members.

  22. Method • 20 ml of peripheral blood • DNA extracted and purified • PCR amplification of each of the 9 microsatellite markers • Southern blot

  23. Marker No. of subjects Type of Allele HET PIC SM7 57 9 0.639 0.609 CW2 46 7 0.789 0.760 AC2.5 54 9 0.754 0.720 SM6 54 14 0.652 0.635 KG8 56 4 0.246 0.229 D16S521 51 11 0.639 0.609 D4S231 52 10 0.840 0.807 D4S1563 57 7 0.775 0.741 D4S414 54 9 0.823 0.793 Microsatellite Characterization

  24. PKD1 Markers in Family A

  25. PKD2 Markers in Family A

  26. PKD1 Markers in Family D (SM7) (SM6) IIa IIa IIb IIb IIc IIc Ia Ia Ib Ib Z,Z Z,Z Z,Z+4 Z,Z+4 Z,Z+4 Z,Z+6 Z,Z+4 Z+2,Z+4 Z+4,Z+6 Z+2,Z+6 (CW2) (KG8) Z,Z Z,Z Z,Z Z-1,Z Z,Z+1 Z,Z+2 Z,Z+2 Z,Z+2 Z-1,Z+2 Z-1,Z+1 (AC2.5) (D16S521) Z,Z Z,Z Z,Z Z,Z+6 Z,Z+5 Z,Z+4 Z,Z+4 Z,Z+4 Z,Z+5 Z+5,Z+6

  27. PKD2 Markers in Family D

  28. PKD1 Markers in family E (SM7) (SM6) Ic Ic IIb IIb IIa IIa Ib Ib Ia Ia Z,Z Z,Z Z-4,Z Z-9,Z Z,Z+4 Z-5,Z Z-9,Z Z-4,Z+2 Z-4,Z+6 Z,Z+6 (CW2) (KG8) Z,Z Z,Z Z-3,Z Z-2,Z Z-2,Z Z-2,Z Z-2,Z Z-2,Z-1 Z-3,Z-2 Z-3,Z+1 (AC2.5) (D16S521) Z,Z Z,Z Z,Z Z,Z+2 Z,Z+6 Z,Z+6 Z,Z+6 Z,Z+6 Z,Z+6 Z+6,Z+7

  29. Family Generation No. of Member ADPKD1 ADPKD2 A 2 6 + - B 2 8 ++ -- C 3 18 +++ -- D 2 5 - - E 2 5 ND ND Results of Genetic Diagnosis

  30. PKD3 - Is there one? • 2001 (Pei et al) • evidence of bilineal disease and trans-heterozygotes in a large family of ADPKD • 28/48 members affected • SSCA screened for and found a PKD2 mutation (2152delA; L736X) in 12 affected pedigree members • linkage analysis with markers at the PKD1 locus, found significant LOD scores (13.0).

  31. PKD3 - Is there one? • 2001 (Pei et al) • evidence of bilineal disease and trans-heterozygotes in a large family of ADPKD • 28/48 members affected • in 2/48, who had severe disease, evidence of trans-heterozygotes

  32. 1. Hereditary Kidney Diseases Adult Polycystic Disease [Infantile Polycystic Disease] Alport Syndrome

  33. Infantile Polycystic Kidney Disease • Autosomal recessive. • Usually incompatible with life. • Early antenatal diagnosis for termination of pregnancy is desirable.

  34. Infantile Polycystic Disease • In infantile PKD, the liver is always affected. • The abnormal bile ducts in the liver are accompanied by periductal fibrosis. Hence called congenital hepatic fibrosis.

  35. Localization of PKHD1 • 1994 • Gene locus in 6p12.1-p21. • 2002 (Ward et al) • PKHD1 cloned • 16kb transcript, 4,074 a.a. receptor-like protein called fibrocystin • Missense and truncating mutationsidentified in 14 probands

  36. Genetics of PKHD • Compound heterozygosity. • Double truncating mutations – severe disease. • Some families with mild disease show compound heterozygosity for a missense and a truncating mutation.

  37. 1. Hereditary Kidney Diseases Adult Polycystic Disease Infantile Polycystic Disease [Alport Syndrome]

  38. Alport Syndrome • A hereditary disorder of basement membrane collagen characterized clinically by hematuria, progressive renal failure, and, frequently, neurosensory hearing loss and ocular abnormalities.

  39. Alport Syndrome • Genetically heterogeneous. • In the majority of cases, the disease is inherited as an X-linked trait, but an autosomal recessive form and also an autosomal dominant form exist.

  40. Alport Syndrome • X-link recessive: mutations of COL4A5 on Xq22. • X-link recessive associated with diffuse leiomyomatosis: mutations of COL4A5 and COL4A6. • Autosomal recessive: mutations of COL4A3 and COL4A4 on 2q. • Autosomal dominant : no mutation in any of the COL4 genes.

  41. Prenatal Diagnosis of AS • X-link recessive: by genetic linkage analysis using polymorphic markers in and around COL4A5. • Autosomal recessive: by genetic linkage analysis using polymorphic markers in and around COL4A3 and COL4A4.

  42. Fabry disease

  43. Fabry disease The story begins…

  44. Fabry disease • X-linked recessive inborn error of glycosphingolipid catabolism that results from the deficient activity of the lysosomal enzyme α-galactosidase A (EC 3.2.1.22). • Accumulation of glycosphingolipid substrates in the vascular endothelium causing occlusive microvascular diseases mainly affecting the kidney, the heart, peripheral nerves and the brain.

  45. F/50 Southern Chinese • Asymptomatic proteinuria • 24 hour urine protein 0.6 g • No skin or corneal lesions • Normal renal function tests

  46. Family history • Mother died of kidney disease • 4 siblings • one younger brother (age 44) in end stage renal failure since age of 35 • one younger brother (age 41) has cardiomyopathy since age of 33, not in renal failure

  47. Renal Biopsy Diagnosis • Consistent with heterozygous Fabry disease

  48. Diagnosis Confirmed • Consistent withheterozygous Fabry disease • Low serum α-galactosidase A activity at 5.2nmol/ml.hr • (normal range: 8.8-14.5nmol/ml.hr) • Low serum α-galactosidase A activity in both brothers (both at <0.5nmol/ml.hr)

More Related